精神障碍及其治疗：对慢性肝病患者预后的影响
Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease.
作者信息
Holmes Rachel, Patel Anahli, Desai Archita P
机构信息
Division of Gastroenterology and Hepatology Indiana University School of Medicine Indianapolis IN.
出版信息
Clin Liver Dis (Hoboken). 2022 May 23;20(2):32-37. doi: 10.1002/cld.1204. eCollection 2022 Aug.
Abstract
Content available: Audio Recording.
摘要
提供的内容
音频记录。
相似文献
1
Psychiatric Disorders and Their Treatment: Impact of Outcomes in Patients With Chronic Liver Disease.精神障碍及其治疗：对慢性肝病患者预后的影响
Clin Liver Dis (Hoboken). 2022 May 23;20(2):32-37. doi: 10.1002/cld.1204. eCollection 2022 Aug.
2
Treatment of Mental Health in Patients With Chronic Liver Disease.慢性肝病患者的心理健康治疗
Clin Liver Dis (Hoboken). 2022 May 23;20(2):57-60. doi: 10.1002/cld.1200. eCollection 2022 Aug.
3
Audio Recording Patient-Nurse Verbal Communications in Home Health Care Settings: Pilot Feasibility and Usability Study.家庭医疗环境中患者-护士言语交流的音频记录：初步可行性和可用性研究
JMIR Hum Factors. 2022 May 11;9(2):e35325. doi: 10.2196/35325.
4
Assessment of mental health in patients with chronic liver disease.慢性肝病患者的心理健康评估。
Clin Liver Dis (Hoboken). 2022 Jul 16;20(2):52-56. doi: 10.1002/cld.1214. eCollection 2022 Aug.
5
Association of Video Completed by Audio in Laparoscopic Cholecystectomy With Improvements in Operative Reporting.腹腔镜胆囊切除术音频辅助视频对手术报告改善的关联
JAMA Surg. 2020 Jul 1;155(7):617-623. doi: 10.1001/jamasurg.2020.0741.
6
PRO: Patients With Acute-on-Chronic Liver Failure Should Receive Priority on the Liver Transplant Waiting List.专业观点：慢性肝病急性肝衰竭患者应在肝移植等待名单上获得优先排序。
Clin Liver Dis (Hoboken). 2022 May 20;19(5):203-206. doi: 10.1002/cld.1194. eCollection 2022 May.
7
Sociodemographic Risk Factors for Depression in Patients With Chronic Liver Disease.慢性肝病患者抑郁的社会人口学风险因素
Clin Liver Dis (Hoboken). 2022 May 27;20(2):38-42. doi: 10.1002/cld.1208. eCollection 2022 Aug.
8
Audio-video recording during laparoscopic surgery reduces irrelevant conversation between surgeons: a cohort study.腹腔镜手术期间的音频视频记录可减少外科医生之间的无关对话：一项队列研究。
BMC Surg. 2018 Nov 6;18(1):92. doi: 10.1186/s12893-018-0428-x.
9
Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease.慢性肝病患者酒精及其他物质使用情况的评估
Clin Liver Dis (Hoboken). 2022 May 23;20(2):61-65. doi: 10.1002/cld.1203. eCollection 2022 Aug.
10
A Primer to the Diagnostic and Clinical Utility of Spleen Stiffness Measurement in Patients With Chronic Liver Disease.慢性肝病患者脾脏硬度测量的诊断及临床应用入门
Clin Liver Dis (Hoboken). 2022 Jan 28;19(3):124-130. doi: 10.1002/cld.1185. eCollection 2022 Mar.
引用本文的文献
1
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease.慢性肝病患者减少酒精使用动机的相关因素
Aliment Pharmacol Ther. 2025 Feb;61(3):481-490. doi: 10.1111/apt.18387. Epub 2024 Nov 11.
2
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction-associated steatotic liver disease.代谢相关脂肪性肝病患者的心理社会风险因素与肝移植评估结果的相关性。
Liver Transpl. 2024 Dec 1;30(12):1226-1237. doi: 10.1097/LVT.0000000000000421. Epub 2024 Jun 12.
3
Antidepressants in People With Chronic Liver Disease and Depression: When Are They Warranted and How to Choose the Suitable One?慢性肝病合并抑郁症患者的抗抑郁药：何时适用以及如何选择合适的药物？
J Clin Exp Hepatol. 2024 Jul-Aug;14(4):101390. doi: 10.1016/j.jceh.2024.101390. Epub 2024 Feb 27.
4
Closing the Care Gap: Management of Alcohol Use Disorder in Patients with Alcohol-associated Liver Disease.缩小治疗差距：酒精性肝病患者酒精使用障碍的管理
Clin Ther. 2023 Dec;45(12):1189-1200. doi: 10.1016/j.clinthera.2023.09.017. Epub 2023 Dec 4.
5
Advanced Biomarkers of Hepatotoxicity in Psychiatry: A Narrative Review and Recommendations for New Psychoactive Substances.精神医学中肝毒性的先进生物标志物：新精神活性物质的叙述性综述和建议。
Int J Mol Sci. 2023 May 28;24(11):9413. doi: 10.3390/ijms24119413.
6
Mental Health, Quality of Life, and Stigmatization in Danish Patients with Liver Disease.丹麦肝病患者的心理健康、生活质量和污名化问题。
Int J Environ Res Public Health. 2023 Apr 13;20(8):5497. doi: 10.3390/ijerph20085497.
本文引用的文献
1
Influence of Psychological Biomarkers on Therapeutic Adherence by Patients with Non-Alcoholic Fatty Liver Disease: A Moderated Mediation Model.心理生物标志物对非酒精性脂肪性肝病患者治疗依从性的影响：一个有调节的中介模型。
J Clin Med. 2021 May 20;10(10):2208. doi: 10.3390/jcm10102208.
2
Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).多中心随机对照试验（INTRO-HCV）：对注射吸毒者丙型肝炎病毒感染的综合治疗。
PLoS Med. 2021 Jun 1;18(6):e1003653. doi: 10.1371/journal.pmed.1003653. eCollection 2021 Jun.
3
Only partial improvement in health-related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real-world setting-results from the German Hepatitis C-Registry (DHC-R).直接作用抗病毒药物治疗慢性丙型肝炎病毒感染的真实世界疗效：仅部分改善健康相关生活质量——德国丙型肝炎注册研究（DHC-R）的结果。
J Viral Hepat. 2021 Aug;28(8):1206-1218. doi: 10.1111/jvh.13546. Epub 2021 Jun 8.
4
Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure.照顾中的丙型肝炎患者治疗启动的心理社会障碍：治愈链中的一个障碍。
Hepatol Commun. 2020 Nov 29;5(3):400-411. doi: 10.1002/hep4.1632. eCollection 2021 Mar.
5
Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.一种简短的、同伴提供的自我管理干预措施对罕见慢性疾病患者的疗效：一项随机临床试验。
JAMA Psychiatry. 2021 Jun 1;78(6):607-615. doi: 10.1001/jamapsychiatry.2020.4783.
6
Frequency Of Depression Among Patients With Chronic Liver Disease.慢性肝脏疾病患者的抑郁频率。
J Ayub Med Coll Abbottabad. 2020 Oct-Dec;32(4):535-539.
7
Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: common pathways and future approaches.非酒精性脂肪性肝病（NAFLD）作为精神疾病被忽视的代谢伴发疾病：共同途径和未来方法。
BMC Med. 2020 Oct 1;18(1):261. doi: 10.1186/s12916-020-01713-8.
8
Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review.酒精成瘾、肠道微生物群与酒精中毒治疗：综述
Int J Mol Sci. 2020 Sep 3;21(17):6413. doi: 10.3390/ijms21176413.
9
Opioid Use Is More Common in Nonalcoholic Fatty Liver Disease Patients with Cirrhosis, Higher BMI, and Psychiatric Disease.非酒精性脂肪性肝病合并肝硬化、更高 BMI 和精神疾病的患者中，阿片类药物的使用更为常见。
Dig Dis. 2021;39(3):247-257. doi: 10.1159/000511074. Epub 2020 Aug 24.
10
Low Hepatitis C Reinfection Following Direct-acting Antiviral Therapy Among People Who Inject Drugs on Opioid Agonist Therapy.在接受阿片类激动剂治疗的药物注射者中，直接作用抗病毒治疗后丙型肝炎再感染率较低。
Clin Infect Dis. 2020 Jun 10;70(12):2695-2702. doi: 10.1093/cid/ciz693.
Zotero 插件